Biotech Stocks Growth Stocks Healthcare Stocks Life Sciences Mid Cap Stocks Small Caps Stocks

ASX Biotech Investing In 2026: Investors Are More Aware Of The Hard Lessons, But Have Forgotten The Hidden Rewards Of It

ASX Biotech Investing has always been the market’s most difficult arena. Yes tech and resources are risky spaces too, but at least a gold explorer can gain just off the…

ByNick Sundich

16

Mar 2026

Biotech Stocks Healthcare Stocks Life Sciences

Here are 5 ASX Biotech Targets Amidst The $230bn Patent Cliff; And Which Big Pharma Companies Could Buy Them!

There are plenty of ASX Biotech Targets that major pharmaceutical companies wanting to minimise the impact of the Patent Cliff could look at. For those who don't know what the patent…

ByNick Sundich

18

Aug 2025

Healthcare Stocks International Stocks

ASX Health Care Stocks Under Trump: Who’ll Win and Who’ll Lose?

What does the next few years hold for ASX Health Care Stocks Under Trump? There's no doubt that the health care sector is bearing a greater brunt than any other…

ByNick Sundich

15

Apr 2025

Healthcare Stocks

Neuren Pharmaceuticals (ASX:NEU): Another exciting chapter is yet to come with NNZ-2591

Neuren Pharmaceuticals (ASX:NEU) is an ASX biotech company that has had a stellar past few years, but it is now facing the question: 'Where to now?' Companies with just one…

ByNick Sundich

26

Apr 2024

Uncategorized

5 ASX Health stocks to add to your porfolio

5 ASX Health Stocks Stuart Roberts from Stocks Down Under discussed the potential promise of biotech, sharing his perspectives about the industry's future amidst changing interest rates. He compares the…

ByMarc Kennis

14

Dec 2023

Healthcare Stocks

Why have Nеurеn shares risen over 1100% in the last 2 years?

Nеurеn Pharmacеuticals (ASX:NEU) is a company that has achieved the ultimate dream of all biotechs. Namely, to successfully bring a drug through the clinic. There are few (if any) other…

ByUjjwal Maheshwari

09

Oct 2023

Healthcare Stocks

FDA approval: Here’s how ASX biotechs and medtechs obtain it

Last week one of our favourite companies Cyclopharm (ASX:CYC) obtained FDA approval, a goal it had been striving for years to obtain and one that wasn't reached without setbacks along…

ByNick Sundich

06

Sep 2023

Healthcare Stocks

The 3 best ASX biotech stocks for September!

Here are a trio of companies that we think are the best ASX biotech stocks for September! What are the Best stocks to invest in right now? Check our buy/sell stock…

ByNick Sundich

28

Jul 2023

Uncategorized

ASX Life Sciences stocks: Here are 2 of the best!

ASX Life Sciences stocks discussed by Stuart Roberts as interest rates peak What are the Best ASX Stocks to invest in right now? Check our buy/sell tips on the top…

ByMarc Kennis

24

Feb 2023

Life Sciences

Why did biotech shares underperform in 2022 and will they rebound with a vengence in 2023?

In the past year, biotech shares have performed poorly. Why has this been the case and will things be better in 2023? SIGN UP FOR THE STOCKS DOWN UNDER NEWSLETTER NOW!…

ByNick Sundich

ASX Biotech Investing In 2026: Investors Are More Aware Of The Hard Lessons, But Have Forgotten The Hidden Rewards Of It

Here are 5 ASX Biotech Targets Amidst The $230bn Patent Cliff; And Which Big Pharma Companies Could Buy Them!

ASX Health Care Stocks Under Trump: Who’ll Win and Who’ll Lose?

Neuren Pharmaceuticals (ASX:NEU): Another exciting chapter is yet to come with NNZ-2591

5 ASX Health stocks to add to your porfolio

Why have Nеurеn shares risen over 1100% in the last 2 years?

FDA approval: Here’s how ASX biotechs and medtechs obtain it

The 3 best ASX biotech stocks for September!

ASX Life Sciences stocks: Here are 2 of the best!

Why did biotech shares underperform in 2022 and will they rebound with a vengence in 2023?

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Add Your Heading Text Here